leisure time -WSS

leisure time

author：hotspot 2025-10-01 02:42:31 - browse：6897

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： How a Boston hospital is priming medical residents to use GPT

WSS

PrEP can help anyone prevent HIV. Why do so few people take it?

Inside the culture of fear in the White House science office of Eric Lander

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

FAMU bans football players from facility after release of rap video shot in team's locker room

entertainment

leisure time

focus

Medicare proposal to cover medical devices draws a mixed reaction

US jobless claims fall again as labor market continues to flash strength

Continuity nursing helped my family in our darkest PICU moments

New requirements coming in 2024 for Americans traveling to Europe

Psychedelics group wrestles with new pharma identity

Are infertility treatments 'essential' during the Covid

Affirmative action in medical school literally saved lives

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Moonlake's readout produced a cash windfall. Risks remain

Stanford president’s abrupt resignation sparks debate

knowledge

How to protect coverage of PrEP

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Mystery swirls around US soldier who entered North Korea days ago, officials say

Hormonal contraceptives don’t actually treat endometriosis

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

leisure time

focus

focus

leisure time